Michael A. Panzara - Mar 18, 2022 Form 4 Insider Report for Athira Pharma, Inc. (ATHA)

Role
Director
Signature
Glenna Mileson, Attorney-in-fact for Michael Panzara
Stock symbol
ATHA
Transactions as of
Mar 18, 2022
Transactions value $
$0
Form type
4
Date filed
3/21/2022, 04:40 PM
Previous filing
Feb 18, 2022
Next filing
May 6, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATHA Stock Option (Right to Buy) Award $0 +27.7K $0.00 27.7K Mar 18, 2022 Common Stock 27.7K $10.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth of the shares subject to the option will vest on April 18, 2022 and one thirty-sixth of the shares subject to the option will vest each month thereafter.